Nasdaq staff initiates delisting of Atlantic American Corp.
Atlantic American Corp. received a Staff Delisting Determination from Nasdaq due to the delayed filing of its 2025 Form 10-K and 10-Qs. The company filed the 10-K and is appealing …
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Atlantic American Corp. received a Staff Delisting Determination from Nasdaq due to the delayed filing of its 2025 Form 10-K and 10-Qs. The company filed the 10-K and is appealing …
The FDA has announced the creation of the Neuroscience Advancement and Innovation Nexus (NAIN) to accelerate medical innovation and deliver breakthrough treatments.
SenesTech received a Nasdaq notification of noncompliance due to a 30-day closing bid price below $1.00, though trading continues. Management cited record third-quarter revenue gro…
MIRA Pharmaceuticals posted positive preclinical results for its pain drug candidate MIRA-55, demonstrating the potential to rival popular drugs like Celebrex for chronic inflammat…
Arbutus Biopharma announced that the FDA has lifted the clinical hold on its Investigational New Drug application for AB-101, an oral PD-L1 inhibitor, allowing the company to furth…
Sagimet Biosciences disclosed forward-looking statements and risks for denifanstat in an internal presentation, outlining various development uncertainties. The disclosure is signi…
Preclinical data shows KRRO-111 achieves over 95% SERPINA1 editing, restoring functional lung protein and reducing toxic liver buildup, potentially initiating regulatory submission…
Cognition Therapeutics (CGTX) announced that the FDA has aligned on key elements for its pivotal Phase 3 study in Dementia with Lewy Bodies (DLB), targeting participants with mild-…
The company is withdrawing its listing from Nasdaq and likely ending its SEC reporting obligations, trading instead on the OTC markets under the ticker DRCT.
Caci International Inc. filed an amended and restated bylaws document, effective October 20, 2026, outlining new corporate procedures.
Consolidated Water secured key permits for its Kalaeloa seawater desalination project, scheduling construction for early 2027 due to delays. The Hawaii Board of Water Supply issued…
Pine Tree Acquisition Corp. announced that holders of its units can trade separately as PAXG Class A shares and PAXGR rights, at Nasdaq. The company is led by CEO Wei Qian.
Roivant and Priovant announced positive results from the Phase 3 CLARITY program evaluating brepocitinib in non-infectious uveitis, setting the stage for a potential new treatment …
Vivos Therapeutics, Inc. has received a letter from The Nasdaq Stock Market confirming its continued compliance with the stockholders' equity standard following a major equity tran…
North America's largest antimony project, Nova Metals' plan to build a critical minerals hub, benefits from a major US infrastructure investment to link it to supply chains.
The FDA approved Hibsago injection for treating chronic HBV in adults without cirrhosis when taken with existing antivirals.
SEGG Media requested an appeal after receiving a Staff Determination for late 10-Q filing, requesting a hearing to prevent immediate trading suspension.
Safe Harbor Financial received a reprieve until April 19, 2027, to regain compliance with Nasdaq's $1 minimum bid price rule after previously failing to meet the requirement.
Anavex completed clinical conduct for DDI and ADME studies of blarcamesine, aiding the Alzheimer's pipeline; FDA cleared an IND for Fragile X syndrome. These developments reflect s…
Eastman Chemical Company filed an amended and restated bylaws with the SEC, effective immediately.